You just speculated on the length of the trials but we already know the studies can be short in duration. A full blown PH3 is not required unless you are also speculating on a once a day Oxycontin. An ANDA for example would be a very small study 1-3 months and a 505B2 may not be much bigger,

How many products have launched in the past 18 months?

Which product do you think is being referred to for these studies?

Two simple questions any investor can answer